Olink

Olink®
Part of Thermo Fisher Scientific

Impact of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the atopic dermatitis serum proteome

Annals of Allergy, Asthma & Immunology, 2022

Kim M., Ungar B., Estrada Y., Pavel A., Guttman-Yassky E.

Disease areaApplication areaSample typeProducts
Immunological & Inflammatory Diseases
Pathophysiology
Serum
Olink Target 96

Olink Target 96

Abstract

No abstract (letter format article).

Read publication ↗